PRMT5, a type II arginine methyltransferase, functions as a tumor initiator to regulate cancer progression by symmetric dimethylation of arginine residues on histone proteins4,34, and regulates important cellular functions, including cell growth, proliferation, and differentiation35–37. The gene discussed is PRMT5; the disease is neoplasm.